Among 92 endometrial carcinomas analyzed by NGS and HER2 IHC-FISH, 10 (10.9%) had ERBB2 gene amplification by NGS, all of which were HER2-positive by IHC-FISH. This evidence concerns the gene ERBB2 and endometrial carcinoma.